Evidence map›Paper›PMID 21950777›Full record

ArticleBritish journal of pharmacology2012

Characteristics of concatemeric GABA(A) receptors containing α4/δ subunits expressed in Xenopus oocytes.

Hong-Jin Shu, John Bracamontes, Amanda Taylor, Kyle Wu, Megan M Eaton, Gustav Akk, Brad Manion, Alex S Evers, Kathiresan Krishnan, Douglas F Covey and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  4. Article
  5. Review
  6. GABAFrontiers in cellular neuroscience · 2020
    Article
  7. Lack of Neurosteroid Selectivity at δ vs. γ2-Containing GABAFrontiers in molecular neuroscience · 2020
    Article
  8. Article
  9. Article
  10. Chemogenetic Isolation Reveals Synaptic Contribution of δ GABAThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  11. Comparison of αβδ and αβγ GABAPharmacological research · 2018
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Hong-Jin ShuDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
John Bracamontes
Amanda Taylor
Kyle Wu
Megan M Eaton
Gustav Akk
Brad Manion
Alex S Evers
Kathiresan Krishnan
Douglas F Covey
Charles F Zorumski
Joe Henry Steinbach
Steven Mennerick
Washington University in St. Louis · USInstitute of Developmental Physiology · RU

Funding

STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUESP01GM047969 · NIGMS · WASHINGTON UNIVERSITY · PI COVEY, DOUGLAS F · 1992 to 2011
$18.7M
ETHANOL, NEUROSTEROIDS & HIPPOCAMPAL PLASTICITYR01AA017413 · NIAAA · WASHINGTON UNIVERSITY · PI ZORUMSKI, CHARLES F · 2009 to 2013
$1.8M
Axonal Signaling in the HippocampusR01NS054174 · NINDS · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J · 2006 to 2010
$1.5M
NIAAA NIH HHS AA017413NIAAA NIH HHS R01 AA017413NIGMS NIH HHS GM47969NIGMS NIH HHS P01 GM047969NINDS NIH HHS NS54174NINDS NIH HHS R01 NS054174
6 · The paper itself

Abstract

background and purposeGABA(A) receptors mediate both synaptic and extrasynaptic actions of GABA. In several neuronal populations, α4 and δ subunits are key components of extrasynaptic GABA(A) receptors that strongly influence neuronal excitability and could mediate the effects of neuroactive agents including neurosteroids and ethanol. However, these receptors can be difficult to study in native cells and recombinant δ subunits can be difficult to express in heterologous systems. EXPERIMENTAL APPROACH: We engineered concatemeric (fused) subunits to ensure δ and α4 subunit expression. We tested the pharmacology of the concatemeric receptors, compared with a common synaptic-like receptor subunit combination (α1 +β2 +γ2L), and with free-subunit α4/δ receptors, expressed in Xenopus oocytes. KEY

resultsδ-β2 -α4 +β2-α4 cRNA co-injected into Xenopus oocytes resulted in GABA-gated currents with the expected pharmacological properties of α4/δ-containing receptors. Criteria included sensitivity to agonists of different efficacy, sensitivity to the allosteric activator pentobarbital, and modulation of agonist responses by DS2 (4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl benzamide; a δ-selective positive modulator), furosemide, and Zn(2+) . We used the concatemers to examine neurosteroid sensitivity of extrasynaptic-like, δ-containing receptors. We found no qualitative differences between extrasynaptic-like receptors and synaptic-like receptors in the actions of either negative or positive neurosteroid modulators of receptor function. Quantitative differences were explained by the partial agonist effects of the natural agonist GABA and by a mildly increased sensitivity to low steroid concentrations. CONCLUSIONS AND IMPLICATIONS: The neurosteroid structure-activity profile for α4/δ-containing extrasynaptic receptors is unlikely to differ from that of synaptic-like receptors such as α1/β2/γ2-containing receptors.

Indexed as

AnimalsFemaleGABA AgonistsGABA AntagonistsHumansIn Vitro TechniquesNeurotransmitter AgentsOocytesPatch-Clamp TechniquesProtein EngineeringProtein SubunitsRatsReceptors, GABA-ARecombinant Fusion ProteinsXenopus laevisGABA AgonistsGABA AntagonistsNeurotransmitter AgentsProtein SubunitsReceptors, GABA-ARecombinant Fusion Proteins

Identifiers

PMID21950777
PMCPMC3413859
OpenAlexW1548044390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.